Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-23

Clinical Trial Update: Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of linaclotide on the brain-gut axis in patients with irritable bowel syndrome with constipation (IBS-C).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linzess (linaclotide)

Snippet

Sponsor: Augusta University | Conditions: Irritable Bowel Syndrome With Constipation (IBS-C) | NA | Status: COMPLETED